We are live on ! Find out more
SKYE icon

Skye Bioscience
SKYE

62 hedge funds and large institutions have $196M invested in Skye Bioscience in 2024 Q2 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

87.27% more ownership

Funds ownership: 0% → 87.27% (+87%)

0% more call options, than puts

Call options by funds: $9K | Put options by funds: $9K

Holders
62
Holders Change
+62
Holders Change %
–
% of All Funds
0.9%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.07%
New
62
Increased
–
Reduced
–
Closed
–
Calls
$9K
Puts
$9K
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
5VM
5AM Venture Management
California
+$121M
2
VVM
Versant Venture Management
California
+$23.8M
3
ACM
Altium Capital Management
New York
+$16M
4
LGM
Logos Global Management
California
+$15.4M
5
SFM
Sphera Funds Management
Israel
+$15.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
26
BNP Paribas Financial Markets
France
$222K +$329K +27,713 New
AI
27
AdvisorShares Investments
Maryland
$210K +$309K +26,000 New
N
28
Nuveen
North Carolina
$187K +$278K +23,389 New
Morgan Stanley
29
Morgan Stanley
New York
$172K +$255K +21,472 New
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$158K +$234K +19,754 New
AGM
31
Alpine Global Management
New York
$135K +$199K +16,807 New
JP Morgan Chase
32
JP Morgan Chase
New York
$120K +$178K +14,971 New
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$111K +$164K +13,800 New
Bank of America
34
Bank of America
North Carolina
$92.7K +$137K +11,570 New
CF
35
Corebridge Financial
Texas
$74.3K +$110K +9,264 New
Deutsche Bank
36
Deutsche Bank
Germany
$70.3K +$104K +8,781 New
Wells Fargo
37
Wells Fargo
California
$58.2K +$86.3K +7,272 New
PD
38
Point72 (DIFC)
United Arab Emirates
$48.1K +$71.2K +6,000 New
UBS Group
39
UBS Group
Switzerland
$42.1K +$62.3K +5,250 New
MIM
40
MetLife Investment Management
New Jersey
$38.4K +$56.9K +4,796 New
Citigroup
41
Citigroup
New York
$30.8K +$45.7K +3,848 New
CSS
42
Cubist Systematic Strategies
Connecticut
$30.1K +$44.6K +3,762 New
SO
43
STRS Ohio
Ohio
$25.6K +$38K +3,200 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$14K +$20.3K +1,709 New
AIP
45
Ameritas Investment Partners
Nebraska
$13.5K +$20K +1,687 New
FGAM
46
Financial Gravity Asset Management
Texas
$12.8K +$19K +1,600 New
Legal & General Group
47
Legal & General Group
United Kingdom
$11.9K +$17.6K +1,486 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$10K +$14.8K +1,248 New
AB
49
Amalgamated Bank
New York
$5K +$7.07K +596 New
FDCDDQ
50
Federation des caisses Desjardins du Quebec
Quebec, Canada
$409 +$605 +51 New
1
2
3

SKYE Hedge Fund Activity: Q2 2024 in Review

62 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Skye Bioscience (SKYE) for Q2 2024, worth a combined $196M.

Buyers outnumbered sellers: 62 funds opened new SKYE positions and 0 closed out — a net gain of 62 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was 5AM Venture Management, opening a new position worth an estimated $121M.

  • 62 institutional investors held Skye Bioscience (SKYE) as of Q2 2024, up from 0 in Q1 2024.
  • Funds reported $196M of Skye Bioscience stock for Q2 2024.
  • 62 funds opened new Skye Bioscience positions in Q2 2024 and 0 closed out, a net change of +62 holders.
  • The largest Skye Bioscience buyer in Q2 2024 was 5AM Venture Management, an estimated $121M added.

Based on aggregated 13F filings for Q2 2024.